• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病和痴呆发病的脑葡萄糖代谢特征:纵向研究。

Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.

机构信息

Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, Michigan 48109-0028, USA.

出版信息

J Nucl Med. 2011 Jun;52(6):848-55. doi: 10.2967/jnumed.111.089946. Epub 2011 May 13.

DOI:10.2967/jnumed.111.089946
PMID:21571793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7486964/
Abstract

UNLABELLED

Longitudinal studies in nondemented Parkinson disease (PD) subjects offer an opportunity to study the earliest regional cerebral subcortical and cortical metabolic changes underlying incident dementia in this disorder.

METHODS

Twenty-three PD subjects without dementia (Hoehn and Yahr stages I-III; age, 61.8 ± 9.7 y; Mini-Mental State Examination, 28.0 ± 1.4) and 27 controls (age, 59.8 ± 11.5 y) underwent (18)F-FDG PET at study entry. PD subjects underwent yearly clinical assessment to determine conversion to dementia. The mean duration of follow-up was 3.9 ± 1.2 y (range, 2.0-6.8 y). Follow-up (18)F-FDG PET was available in a subset of subjects at 2 or more years. Both volume-of-interest and 3-dimensional stereotactic surface projection (3D-SSP) analyses were performed.

RESULTS

Six subjects became demented (PDD), with a mean time of 3.8 ± 1.7 y (range, 1.9-6.0 y) to development of dementia. Mean duration of disease before onset of dementia was 9.7 ± 4.2 y (range, 3.1-14 y). There were significant metabolic reductions in the occipital (-11.8% vs. controls, F((2,22)) = 7.0, P = 0.002) and posterior cingulate (-12.1% vs. controls, F((2,22)) = 5.2, P = 0.009) cortices in PDD subjects at baseline, before diagnosis of dementia, compared with controls. Metabolism was most diminished in the visual association cortex (Brodmann area [BA] 18; -20.0% vs. control, F((2,22)) = 8.45, P = 0.0007) of PDD subjects. There was mild hypometabolism in the caudate nucleus (-8.4% vs. control, F((2,22)) = 3.2, P < 0.05). There was no significant hypometabolism in the temporal or frontal lobes. PD subjects who did not become demented (non-PDD), compared with controls, had reduced cerebral metabolism in the primary occipital cortex (BA 17) that was revealed only by 3D-SSP analysis. Follow-up scans in 5 PDD subjects at 2 y after study entry demonstrated a significant interval within-subject change in the thalamus (-11.4%), posterior cingulate (-9%), occipital (-7%), parietal (-7%), and frontal cortices (-7%) and mild reductions in the temporal cortex (-5%) and hippocampus (-3%), compared with study entry scans.

CONCLUSION

Incident dementia in idiopathic PD is heralded by decreased metabolism in the visual association (BA 18) and posterior cingulate cortices, with mild involvement also of the caudate nucleus. Two-year follow-up data from 5 PDD converters show that progression to dementia is associated with mixed subcortical and cortical changes that involve the mesiofrontal lobes also. These findings provide insights into early metabolic features of parkinsonian dementia.

摘要

目的

在非痴呆帕金森病(PD)患者的纵向研究中,有机会研究该疾病中发生痴呆的潜在认知障碍的早期大脑皮质下和皮质代谢变化。

方法

23 名无痴呆(Hoehn 和 Yahr 分期 I-III;年龄 61.8 ± 9.7 岁;简易精神状态检查 28.0 ± 1.4)和 27 名对照者(年龄 59.8 ± 11.5 岁)在研究开始时接受了(18)F-FDG PET。PD 患者每年进行临床评估以确定是否转化为痴呆。平均随访时间为 3.9 ± 1.2 年(范围 2.0-6.8 年)。在一些患者中,可获得随访 2 年以上的(18)F-FDG PET 扫描。进行了基于感兴趣区和三维立体定向表面投影(3D-SSP)的分析。

结果

6 名患者出现痴呆(PDD),从出现痴呆到发病的平均时间为 3.8 ± 1.7 年(范围 1.9-6.0 年)。在痴呆发病前,疾病的平均病程为 9.7 ± 4.2 年(范围 3.1-14 年)。与对照组相比,基线时(即在诊断为痴呆之前)PDD 患者的枕叶(-11.8%,与对照组相比,F(2,22)=7.0,P=0.002)和后扣带回(-12.1%,与对照组相比,F(2,22)=5.2,P=0.009)皮质代谢明显降低。PDD 患者的视觉联合皮质(Brodmann 区 18;-20.0%,与对照组相比,F(2,22)=8.45,P=0.0007)代谢降低最明显。尾状核轻度代谢低下(-8.4%,与对照组相比,F(2,22)=3.2,P<0.05)。颞叶和额叶未见明显代谢低下。与对照组相比,未发生痴呆的 PD 患者(非 PDD)的初级枕叶皮质(BA 17)的脑代谢降低,仅通过 3D-SSP 分析发现。在研究开始后 2 年对 5 名 PDD 患者进行的随访扫描显示,丘脑(-11.4%)、后扣带回(-9%)、枕叶(-7%)、顶叶(-7%)和额叶(-7%)的脑代谢有明显的间隔内变化,颞叶皮质(-5%)和海马体(-3%)有轻度减少,与研究开始时的扫描相比。

结论

特发性 PD 患者的新发痴呆以视觉联合(BA 18)和后扣带回皮质代谢降低为特征,尾状核也有轻度受累。5 名 PDD 转化者的 2 年随访数据显示,进展为痴呆与涉及中额叶的混合皮质下和皮质变化有关。这些发现为帕金森痴呆的早期代谢特征提供了新的认识。

相似文献

1
Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.帕金森病和痴呆发病的脑葡萄糖代谢特征:纵向研究。
J Nucl Med. 2011 Jun;52(6):848-55. doi: 10.2967/jnumed.111.089946. Epub 2011 May 13.
2
[Cerebral glucose metabolism in Parkinson's disease with dementia].[帕金森病伴痴呆的脑葡萄糖代谢]
Zhonghua Yi Xue Za Zhi. 2008 Oct 14;88(37):2623-8.
3
Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.帕金森病认知障碍相关的脑代谢差异
PLoS One. 2016 Apr 11;11(4):e0152716. doi: 10.1371/journal.pone.0152716. eCollection 2016.
4
Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.帕金森病认知和脑代谢变化的纵向研究。
J Neurol Sci. 2017 Jan 15;372:288-293. doi: 10.1016/j.jns.2016.11.068. Epub 2016 Dec 1.
5
Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.后顶枕叶代谢低下可将帕金森病患者的轻度认知障碍与痴呆区分开。
Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1767-77. doi: 10.1007/s00259-012-2198-5. Epub 2012 Aug 8.
6
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.痴呆症患者脑代谢衰退的纵向PET评估:阿尔茨海默病治疗研究中的一种潜在结局指标
Am J Psychiatry. 2002 May;159(5):738-45. doi: 10.1176/appi.ajp.159.5.738.
7
Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.帕金森病伴和不伴痴呆的小胶质细胞、淀粉样蛋白和葡萄糖代谢。
Neuropsychopharmacology. 2013 May;38(6):938-49. doi: 10.1038/npp.2012.255. Epub 2012 Dec 6.
8
Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.在开期和关期使用[18F]氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)研究晚期帕金森病静息状态下局部脑葡萄糖代谢情况。
Mov Disord. 2001 Nov;16(6):1014-22. doi: 10.1002/mds.1212.
9
[Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].帕金森病认知障碍患者脑葡萄糖代谢特征
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(5):46-51. doi: 10.17116/jnevro20171175146-51.
10
[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.[(11)C]PIB、[(18)F]FDG-PET 和 MRI 成像在伴有和不伴有痴呆的帕金森病患者中的应用。
Parkinsonism Relat Disord. 2010 Dec;16(10):666-70. doi: 10.1016/j.parkreldis.2010.08.021. Epub 2010 Sep 25.

引用本文的文献

1
The role of on cognitive impairment in Parkinson's disease and Parkinsonisms.[具体内容]对帕金森病和帕金森综合征认知障碍的作用。 需注意,原文中“on cognitive impairment”前似乎缺失了关键信息。
Front Neurosci. 2025 Feb 20;19:1515374. doi: 10.3389/fnins.2025.1515374. eCollection 2025.
2
Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson's disease.纹状体多巴胺转运体摄取可预测帕金森病患者的神经元代谢减退和视觉空间功能。
Eur J Nucl Med Mol Imaging. 2025 Feb 14. doi: 10.1007/s00259-025-07137-x.
3
Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson's disease.

本文引用的文献

1
Amyloid imaging of Lewy body-associated disorders.路易体相关疾病的淀粉样蛋白成像。
Mov Disord. 2010 Nov 15;25(15):2516-23. doi: 10.1002/mds.23393.
2
The epidemiology of dementia associated with Parkinson disease.帕金森病相关痴呆的流行病学。
J Neurol Sci. 2010 Feb 15;289(1-2):18-22. doi: 10.1016/j.jns.2009.08.034. Epub 2009 Sep 4.
3
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.通过正电子发射断层扫描(PET)对路易体病中脑乙酰胆碱酯酶改变的映射。
帕金森病认知障碍潜在的皮质神经退行性变的影像学生物标志物。
Eur J Nucl Med Mol Imaging. 2025 May;52(6):2002-2014. doi: 10.1007/s00259-025-07070-z. Epub 2025 Jan 31.
4
Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial.帕金森病患者联合代谢激活剂治疗后认知功能改善的多组学特征:一项随机、双盲、安慰剂对照的II期试验。
Brain Commun. 2025 Jan 6;7(1):fcae478. doi: 10.1093/braincomms/fcae478. eCollection 2025.
5
Longitudinal FDG-PET Metabolic Change Along the Lewy Body Continuum.路易体连续体中的纵向氟代脱氧葡萄糖正电子发射断层扫描代谢变化
JAMA Neurol. 2025 Mar 1;82(3):285-294. doi: 10.1001/jamaneurol.2024.4643.
6
Regional cerebral cholinergic vesicular transporter correlates of visual contrast sensitivity in Parkinson's disease: Implications for visual and cognitive function.帕金森病中区域脑胆碱能囊泡转运体与视觉对比敏感度的相关性:对视觉和认知功能的影响
Parkinsonism Relat Disord. 2025 Feb;131:107229. doi: 10.1016/j.parkreldis.2024.107229. Epub 2024 Dec 9.
7
Cortical hypometabolism in Parkinson's disease is linked to cholinergic basal forebrain atrophy.帕金森病中的皮质低代谢与胆碱能基底前脑萎缩有关。
Mol Psychiatry. 2025 Jun;30(6):2372-2380. doi: 10.1038/s41380-024-02842-9. Epub 2024 Dec 5.
8
Occipital hypoperfusion and motor reserve in Parkinson's disease: an early-phase F-FP-CIT PET study.帕金森病中的枕叶低灌注与运动储备:一项早期¹⁸F - FP - CIT PET研究
NPJ Parkinsons Dis. 2024 Nov 17;10(1):221. doi: 10.1038/s41531-024-00834-8.
9
Structure-function coupling in macroscale human brain networks.宏观人类大脑网络中的结构-功能耦合。
Nat Rev Neurosci. 2024 Oct;25(10):688-704. doi: 10.1038/s41583-024-00846-6. Epub 2024 Aug 5.
10
Radionuclide Imaging of the Neuroanatomical and Neurochemical Substrate of Cognitive Decline in Parkinson's Disease.帕金森病认知功能下降的神经解剖学和神经化学底物的放射性核素成像
Nucl Med Mol Imaging. 2024 Jun;58(4):213-226. doi: 10.1007/s13139-024-00842-9. Epub 2024 Feb 15.
Neurology. 2009 Jul 28;73(4):273-8. doi: 10.1212/WNL.0b013e3181ab2b58. Epub 2009 May 27.
4
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.从正常认知到经病理证实的阿尔茨海默病,大脑葡萄糖代谢中的氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)变化
Eur J Nucl Med Mol Imaging. 2009 May;36(5):811-22. doi: 10.1007/s00259-008-1039-z. Epub 2009 Jan 14.
5
Metabolic alterations in patients with Parkinson disease and visual hallucinations.帕金森病伴视幻觉患者的代谢改变
Arch Neurol. 2007 Jul;64(7):984-8. doi: 10.1001/archneur.64.7.984.
6
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.帕金森病中的痴呆:胆碱能和多巴胺能通路的功能成像
Neurology. 2005 Dec 13;65(11):1716-22. doi: 10.1212/01.wnl.0000191154.78131.f6.
7
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.路易体痴呆的诊断与管理:DLB联盟的第三次报告
Neurology. 2005 Dec 27;65(12):1863-72. doi: 10.1212/01.wnl.0000187889.17253.b1. Epub 2005 Oct 19.
8
The rate of cognitive decline in Parkinson disease.帕金森病认知功能衰退的速率
Arch Neurol. 2004 Dec;61(12):1906-11. doi: 10.1001/archneur.61.12.1906.
9
EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.中枢神经系统中含单胺神经元存在的证据。I. 脑干神经元细胞体中单胺的证实。
Acta Physiol Scand Suppl. 1964:SUPPL 232:1-55.
10
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.轻度认知障碍转化为阿尔茨海默病时伴随的脑代谢变化:一项PET随访研究
Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. doi: 10.1007/s00259-003-1194-1. Epub 2003 May 23.